COST ACTION 920

Inventory of QMRA Studies in Europe

Pathogen

Fluoroquinolone-resistant Salmonella Typhimurium (FQ-STM)

Country or region

 EU

Transmission route

 From

 Farm

To

 Human

Specific product(s)

End-point(s)

Bibliographic reference

Wooldridge, M. (1999). Qualitative risk assessment for antibiotic resistance.  Case study: Salmonella typhimurium and the quinolone/fluoroquinolone class of antimicrobials.  In Antibiotic Resistance in the European Union Associated with the Therapeutic Use of Veterinary Medicines: Report and Qualitative Risk Assessment by the Committee for Veterinary Medicinal Products, The European Agency for the Evaluation of Medicinal Products (EMEA), 7 Westferry Circus, London, UK

Abstract

Investigates the consequence of (fluoro)quinolone use in farm livestock on human health. 
Based on information available at the time, the probability of adverse health effects in humans due to the presence of FQ-STM derived initially from farm livestock due to the use of (fluoro)quinolones in those farm livestock was assessed to be low, but with a high degree of uncertainty on this estimate, and with much variation by country and species of livestock.

Status

Complete

Availability

Contact EMEA or author

Institute

Contact person

Dr. Marion Wooldridge (m.wooldridge@vla.defra.gsi.gov.uk)

Partners